Panbela Therapeutics Top Management
Panbela Therapeutics employs about 6 people. The company is managed by 5 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.2 employees per reported executive. Analysis of Panbela Therapeutics' management performance can provide insight into the company performance.
Panbela |
Panbela Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (1.9187) % which means that it has lost $1.9187 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.9816) %, meaning that it created substantial loss on money invested by shareholders. Panbela Therapeutics' management efficiency ratios could be used to measure how well Panbela Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Panbela Therapeutics Workforce Comparison
Panbela Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 136. Panbela Therapeutics holds roughly 6.0 in number of employees claiming about 4% of equities under Health Care industry.
Panbela Therapeutics Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Panbela Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Panbela Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Panbela Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mathiesen Jeffrey S over a year ago Acquisition by Mathiesen Jeffrey S of 8333 shares of Panbela Therapeutics subject to Rule 16b-3 | ||
Simpson Jennifer K over a year ago Purchase by Simpson Jennifer K of 4444 shares of Panbela Therapeutics |
Panbela Therapeutics Notable Stakeholders
A Panbela Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Panbela Therapeutics often face trade-offs trying to please all of them. Panbela Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Panbela Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| CRNP MSN | President CEO | Profile | |
| Susan Horvath | CFO, Finance | Profile | |
| CRNP CRNP | Pres CEO | Profile | |
| Tammy Groene | Vice Operations | Profile | |
| Elizabeth Bruckheimer | VP Officer | Profile |
Panbela Therapeutics Workforce Analysis
Traditionally, organizations such as Panbela Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Panbela Therapeutics within its industry.Panbela Therapeutics Manpower Efficiency
Return on Panbela Therapeutics Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 5.8M | |
| Net Loss Per Executive | 7M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Panbela Stock
If you are still planning to invest in Panbela Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Panbela Therapeutics' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Directory Find actively traded commodities issued by global exchanges |